ACM sees opportunities for lower prices of `expensive prescription drugs´
(WorldNews Netherlands)

The Netherlands Authority for Consumers and Markets () keeps a close watch on the trends and developments in prescription drugs. One such recent development concerns the manufacturing of orphan drugs by pharmacies (independent ones and hospital pharmacies). This `magistral preparation`, as it is called, provides opportunities for lower prices of `expensive drugs`, as it paves the way for cheaper alternatives. ACM makes sure...